Apoorva Mandavilli. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Benzamides/therapeutic useChildDrug Resistance, NeoplasmHumansImatinib MesylateLeukemia/drug therapyLeukemia/immunologyLeukemia/pathologyLeukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapyNeoplastic Stem Cells/pathologyPiperazines/therapeutic usePrecursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapyPyrimidines/therapeutic use
Substances: See more » BenzamidesPiperazinesPyrimidinesImatinib Mesylate
Year: 2013 PMID: 23803941 DOI: 10.1038/498S1a
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962